Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter


Study Name: Single Dose Safety Study of SB-656933 in People with CF
Study Type: Interventional
Intervention Category: Anti-Inflammatory
Study Sponsor: GSK
Study Phase: 1
Recruitment Status: Trial Completed
Study Drug(s): SB-656933
Number of Participants Being Recruited: 16
Single / Multi-Center: Multi-Center
Some medications taken by people with CF are rapidly cleared by body systems. In the laboratory tests this study medication showed less rapid clearing. This study will look at the effect on safety and clearance from the body after taking one dose of SB-656933 in people with CF.
Age: >= 16 Years
FEV1: >= 40 Percent Predicted
P. aeruginosa status: Not applicable
B. cepacia status: Negative
Other Primary Eligibility Requirements:

Note: Detailed eligibility criteria information may be available on If a specific trial listing for this trial is available, a link to the specific listing will be present in the "More Information" section below.
Sponsor Contact Information: Lazaar, Aili
(610) 270-4026
Trial Specific Link on
Clinical Research Terms Glossary: Click here
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.
  • Stanford University (Adult), Palo Alto, CA, 94305
    Contact Information:
        Dunn, Colleen
        Phone: (650) 736-0388
  • The Minnesota Cystic Fibrosis Center (Adult), Minneapolis, MN, 55455
    Contact Information:
        Grover, Patricia
        Phone: (612) 626-7425
  • University of Pittsburgh School of Medicine (Adult), Pittsburgh, PA, 15213
    Contact Information:
        Hartigan, Elizabeth
        Phone: (412) 692-7060
Back to top